CRS 2010 - Utility of Ultra-High Viscosity Hypromellose in ER Matrix Formulations
Showing that the use of ultra-high viscosity BENECEL K200M in an ER matrix system did not show any advantage in drug release retardation compared to METHOCEL K100M.
Showing that the use of ultra-high viscosity BENECEL K200M in an ER matrix system did not show any advantage in drug release retardation compared to METHOCEL K100M.